Navigation Links
BD Announces FDA 510(k) Clearance of BD Vacutainer(R) Rapid Serum Blood Collection Tube
Date:10/6/2009

the evacuated tube. BD offered the first such device for sale in 1949, the Evacutainer, which was invented by Joseph Kleiner. Producing more than 4 billion units annually for use in human healthcare, veterinary care and medical research, BD remains the world's largest manufacturer of evacuated blood collection tubes.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit http://www.bd.com.

SOURCE BD-Becton Dickinson


'/>"/>
SOURCE BD-Becton Dickinson
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Global Peptide Cancer Therapeutics Market & Pipeline Insight ... The conventional methods developed to prevent and eradicate the ... treatment. These methods are confined to low specificity, safety ... researchers to look for a better solution. It has ...
(Date:8/29/2014)... SILVER SPRING, Md. , Aug. 29, 2014 /PRNewswire/ ... today that the U.S. District Court for the District ... in its favor in the company,s case against Sandoz, ... opinion, Judge Peter Sheridan ruled that U.S. ... Sandoz, Inc., and enjoined Sandoz from marketing its generic ...
(Date:8/29/2014)... -- ChemImage will present a workshop focused on hyperspectral ... Science Society,s 22 nd International Symposium on ... .  Forensic Scientists will be in attendance ... can bring to examination procedures. ... Development at ChemImage, will host a workshop during ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
... FRANCISCO, Calif., June 01, 2007,/PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, ... from ongoing clinical,studies of SNS-595 and SNS-032 at ... being held June 7-10, 2007 in Vienna,Austria. , ... Phase 1 clinical trial of SNS-595 in acute ...
... Zurich, June 1, 2007-Cytos Biotechnology AG is ... presentations of its novel,immunotherapeutic CYT003-QbG10 to treat ... were obtained,and will be presented in different ... Academy of Allergology and Clinical Immunology,(EAACI), taking ...
Cached Medicine Technology:Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 2Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 3CYT003-QbG10 to treat allergy to be presented at the Congress of,the European Academy of Allergology and Clinical Immunology,(EAACI), June 9-13, 2007 2
(Date:8/29/2014)... 2014 A recent article discusses ... a Tokyo clothing store for men with gynecomastia, or male ... or diminishing their problem. Board-certified plastic surgeon Dr. Chasan is ... While many people only associate male breasts with men who ... among men of all ages, often starting in adolescence. Men ...
(Date:8/29/2014)... regarded audiologist , Dr. Mary Ann Larkin has written 4 ... are titled:, , Revealing the Truth About Tinnitus ... The Top 5 Things You Should Know Before Buying a ... , Dr. Mary Anne Larkin choose to write about ... misinformation about each them. The reports are available for immediate ...
(Date:8/29/2014)... August 29, 2014 Healthpointe is pleased ... has joined their practice. Dr. Chuang garners extensive experience ... in minimally-invasive arthroscopic and reconstructive treatments of the knees, ... patients with general and sports-related orthopedic needs. ... medical field. As an Orange County native, he graduated ...
(Date:8/29/2014)... Fort Worth, TX (PRWEB) August 29, 2014 ... the practice website to provide hearing health care tips ... The newly established blog section will offer weekly articles ... broad range of topics including the latest advances in ... to frequently asked questions. The audiologists plan to write ...
(Date:8/29/2014)... 29, 2014 (HealthDay News) -- If you have bunions, taking ... treatment later, an expert says. A bunion is a ... when bone or tissue moves out of place and extends ... can cause debilitating pain and may require surgery to correct, ... Medical Center in Freehold, N.J. To prevent bunions, avoid ...
Breaking Medicine News(10 mins):Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 2Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 3Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 3Health News:Healthpointe is Honored to Induct Orthopedic Surgeon into Their Team 2Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 2Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 3Health News:Take Steps to Control Bunions 2
... BLOOD DETECTIVES -- a documentary from Peabody-Award-winning filmmaker Joseph Lovett in ... 19 at 7:00 PM ET/PT on Discovery Health , ... ... Lovett, in conjunction with the American Society of Hematology ...
... Information Systems, Inc., (Berkshire) a leading provider of e-commerce fulfillment solutions ... Pharmaco LLC. Pharmaco LLC is the supplier of Invisible Veins, ... ... Lenox, MA (PRWEB) November 12, 2008 -- Berkshire Information Systems, Inc. ...
... developed at Bristol University that could revolutionise the way ... at North Bristol NHS Trust (NBT). , Professor Alan ... Bristol have been working for a number of years ... and therefore has no radiation risk unlike conventional mammograms. ...
... Fundamental Fractional Patent Families, MOUNTAIN VIEW, ... Technologies, Inc. and Palomar Medical Technologies, Inc. ... Fractional Technology Open Patent,Program ("FTOPP") to offer ... property in the fractional space. The FTOPP ...
... 11 NBTY, Inc. (NYSE:,NTY) (http://www.NBTY.com ), a ... results for the fiscal fourth,quarter and fiscal year ended ... ended September 30, 2008, net sales were,$602 million compared ... fourth,quarter ended September 30, 2007, an increase of $105 ...
... the condition, doctors say , , TUESDAY, Nov. 11 (HealthDay ... exercise and medications to manage and improve the lives ... more than 5 million Americans. , One ... or hospitalization rates from any cause, as well as ...
Cached Medicine News:Health News:Documentary Examining Deadly Blood Disorders and Lifesaving Research to Premiere on Discovery Health 2Health News:Documentary Examining Deadly Blood Disorders and Lifesaving Research to Premiere on Discovery Health 3Health News:Eliminate Varicose Veins with Invisible Veins, a Product of Pharmaco LLC 2Health News:Eliminate Varicose Veins with Invisible Veins, a Product of Pharmaco LLC 3Health News:New technology could revolutionize breast cancer screening 2Health News:New technology could revolutionize breast cancer screening 3Health News:Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program 2Health News:Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program 3Health News:Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program 4Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 2Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 3Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 4Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 5Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 6Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 7Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 8Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 9Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 10Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 11Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 12Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 13Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 14Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 15Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 16Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 17Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 18Health News:NBTY Reports Fourth Quarter and Fiscal Year Results 19Health News:Gains Against Heart Failure Reported 2Health News:Gains Against Heart Failure Reported 3
... The wrap frame is constructed of ... while minimizing potential breakage. The molded ... a full saddle bridge to distribute weight ... peripheral vision with leaded glass side shields. ...
... Constructed of optical steel base ... overlay. Comes with custom fitted ... create a seal to the ... from oblique angle exposure. Includes ...
... protection Properly manufactured radiation protective eyewear ... Our high quality frames and materials offer ... weight. Our lenses are made of Schott ... industry standards. Most Pulse Glasses are offered ...
... frames are designed with the safety and comfort ... Schott RS-520 (also called SF-6) leaded glass, the ... meet standards, as set for optical clarity, visible ... our eyewear is protecting your eyes, it also ...
Medicine Products: